These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 6446284)

  • 21. The ATPase activity of subfragment-1 from the hypertrophied heart.
    Litten RZ; Brayden JE; Alpert NR
    Biochim Biophys Acta; 1978 Apr; 523(2):377-84. PubMed ID: 148912
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Trinitrophenylation of smooth muscle myosin.
    Srivastava S; Ikebe M; Hartshorne DJ
    Biochem Biophys Res Commun; 1985 Jan; 126(2):748-55. PubMed ID: 3156591
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Myocardial changes during the progression of left ventricular pressure-overload by renal hypertension or aortic constriction: myosin, myosin ATPase and collagen.
    Kozlovskis PL; Fieber LA; Pruitt DK; Bailey BK; Smets MJ; Bassett AL; Kimura S; Myerburg RJ
    J Mol Cell Cardiol; 1987 Jan; 19(1):105-14. PubMed ID: 2951526
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Cellular and molecular aspects of contraction in normal and hypertrophied heart].
    Swynghedauw B
    Nouv Rev Fr Hematol (1978); 1982; 24(3):127-9. PubMed ID: 6182524
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Transition from compensated hypertrophy to intrinsic myocardial dysfunction during development of left ventricular pressure-overload hypertrophy in conscious sheep. Systolic dysfunction precedes diastolic dysfunction.
    Aoyagi T; Fujii AM; Flanagan MF; Arnold LW; Brathwaite KW; Colan SD; Mirsky I
    Circulation; 1993 Nov; 88(5 Pt 1):2415-25. PubMed ID: 8222134
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Effect of myosin and its fragments on some creatine kinase properties].
    Safronova TI; Lyzlova SN
    Ukr Biokhim Zh; 1976; 48(3):310-4. PubMed ID: 134478
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cardiac hypertrophy: useful adaptation or pathologic process?
    Grossman W
    Am J Med; 1980 Oct; 69(4):576-84. PubMed ID: 6448546
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Atrial and ventricular myosin ATPase--divergence with increasing animal species size.
    Syrový I
    Pflugers Arch; 1985 May; 404(1):80-2. PubMed ID: 3160007
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Perhexiline directly inhibits arterial myosin phosphorylation and stimulates cardiac myofibrillar ATPase activity.
    Silver PJ
    Eur J Pharmacol; 1984 Oct; 106(1):217-8. PubMed ID: 6241566
    [No Abstract]   [Full Text] [Related]  

  • 30. Isoenzymic changes in myosin and hypertrophy; adaptation during chronic mechanical overload.
    Swynghedauw B; Delcayre C; Moalic JM; Lecarpentier Y; Ray A; Mercadier JJ; Lompre AM; Aumont MC; Schwartz K
    Eur Heart J; 1982 Apr; 3 Suppl A():75-82. PubMed ID: 6210554
    [No Abstract]   [Full Text] [Related]  

  • 31. Modulation of myosin in right ventricular hypertrophy.
    Wikman-Coffelt J; Lotysh M; Fenner C; Zelis R; Mason DT
    Recent Adv Stud Cardiac Struct Metab; 1975; 8():437-46. PubMed ID: 129838
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cardiac atrial myosin adenosine triphosphatase of animals and humans: distinctive enzymatic properties compared with cardiac ventricular myosin.
    Yazaki Y; Ueda S; Nagai R; Shimada K
    Circ Res; 1979 Oct; 45(4):522-7. PubMed ID: 38914
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Contractile protein transitions in human cardiac overload: reality and limitations.
    Cummins P
    Eur Heart J; 1984 Dec; 5 Suppl F():119-27. PubMed ID: 6241886
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Myosin isoenzymes in normal and hypertrophied human ventricular myocardium.
    Mercadier JJ; Bouveret P; Gorza L; Schiaffino S; Clark WA; Zak R; Swynghedauw B; Schwartz K
    Circ Res; 1983 Jul; 53(1):52-62. PubMed ID: 6222846
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dissociation of myosin light chains and decreased myosin ATPase activity with acidification of synthetic myosin filaments: possible clues to the fate of myosin in myocardial ischemia and infarction.
    Smitherman TC; Dycus DW; Richards EG
    J Mol Cell Cardiol; 1980 Feb; 12(2):149-64. PubMed ID: 6445009
    [No Abstract]   [Full Text] [Related]  

  • 36. Role of cardiac myosin light chains in calcium binding and ATPase activity.
    Wikman-Coffelt J; Higuchi M; Mason DT
    Adv Myocardiol; 1980; 1():375-84. PubMed ID: 6446741
    [No Abstract]   [Full Text] [Related]  

  • 37. Actin-activated adenosine triphosphatase activity of native and N-ethylmaleimide-modified cardiac myosin from normal and thyrotoxic rabbits.
    Banerjee SK; Morkin E
    Circ Res; 1977 Nov; 41(5):630-4. PubMed ID: 143352
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Biochemical aspects of experimental cardiac hypertrophy.
    Matsushita S
    Jpn Circ J; 1976 Oct; 40(10):1147-52. PubMed ID: 136528
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The relation between myosin Ca2+ - and K+ -adenosine triphosphatase activity of heart muscles in mammals of different size.
    Syrový I
    Comp Biochem Physiol B; 1982; 72(2):289-93. PubMed ID: 6126314
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Altered myocardial contractility and energetics in hypertrophied myocardium.
    Takeda N; Nakamura I; Okubo T; Nagano M
    Jpn Circ J; 1990 May; 54(5):540-6. PubMed ID: 2172580
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.